Hebert, Adelaide A.
Rippke, Frank
Weber, Teresa M.
Nicol, Noreen Heer
Funding for this research was provided by:
Beiersdorf
Article History
First Online: 10 June 2020
Compliance with Ethical Standards
:
: A.A. Hebert and N.H. Nicol received compensation from Beiersdorf Inc. for time spent preparing this manuscript. Beiersdorf Inc. funded editorial assistance by Jodie Macoun, PhD, Cube Information Ltd, as well as Open Access of this article.
: In the previous 12 months, Adelaide A. Hebert has received honoraria from Beiersdorf, Biofrontera, Cassiopea, Dermira, Dermavant, Ferrer, Galderma, La Roche-Posay, Novartis, Ortho, ReLife, and Sun and research grants from Cutanea, Brickell, Cassiopea, Dermira, GSK, Leo, Mayne, Novan, Pfizer, Promius, Sienna, and SymBio. In the previous 12 months, Noreen Heer Nicol has served as an advisory board member for Eli Lilly & Co. Frank Rippke and Teresa Weber are employees of Beiersdorf.